ArticleKorean journal of clinical oncology2026
The expression of stemness markers in organoids according to histological subtypes of gastric cancer.
Article in Korean journal of clinical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
purposeGastric cancer is a heterogeneous disease in which cancer stem cell-associated properties may contribute to tumor heterogeneity and progression. This study aimed to establish paired normal and tumor gastric organoids, characterize stemness-related gene expression, and explore its association with organoid formation.
methodsNormal and tumor tissues were obtained from 12 patients with advanced gastric cancer. A total of 28 independent organoid cultures were established from 24 tissue specimens (12 normal and 12 tumor), with selected serial strip specimens divided into segments and cultured independently. Expression of stemness-associated markers (AQP5, CD44, ALDH1A, STMN1, and SOX2) was evaluated by quantitative real-time polymerase chain reaction and compared according to tissue origin, histological subtype, and organoid formation status.
resultsNormal organoids tended to exhibit higher CD44 expression, whereas tumor-derived organoids showed relatively higher ALDH1A expression, although these differences were not statistically significant. Margin-derived normal organoids tended to show higher expression of multiple stemness-associated markers than those derived from tissue adjacent to tumors. Diffuse-type organoids tended to show higher CD44 expression, whereas AQP5, ALDH1A, STMN1, and SOX2 tended to be higher in intestinal-type organoids. Organoid-forming cultures consistently showed higher stemness-marker expression than non-forming cultures, particularly among tumor-derived organoids.
conclusionStemness-associated gene expression varied according to tissue origin, histological subtype, and organoid formation status. Higher stemness-marker expression in organoid-forming cultures suggests a potential association between stemness-related programs and organoid-forming capacity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.